Based on the aforementioned information, we conducted the present study which sought to provide information regarding the role of SOX2‐OT in modulating gene expression of SOX2 as well as its effect in lung cancer therapy resistance and clinical outcomes. The gene discussed is SOX2; the disease is lung cancer.